Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory before it ships. This is the released report for the current batch, exactly as the lab signed it.
SLU-PP-332 — 300mcg
100 Capsules | Metabolic & Exercise-Mimetic Research
SLU-PP-332 is a synthetic estrogen-related receptor (ERR) α/β/γ agonist being investigated as a potential exercise-mimetic compound. ERRs are nuclear receptors involved in regulating mitochondrial function, energy metabolism, fatty-acid utilization, and skeletal-muscle adaptation.
Research on SLU-PP-332 has generated significant interest because activation of the ERR pathway can produce molecular and metabolic changes associated with aerobic exercise.
Key Research Areas
- Mitochondrial function & cellular respiration
- Fatty-acid oxidation
- Energy expenditure
- Skeletal-muscle oxidative capacity
- Exercise endurance
- Metabolic flexibility
- Glucose and insulin sensitivity research
- Body-composition research
Preclinical studies found that SLU-PP-332 increased mitochondrial respiration and oxidative muscle-fiber characteristics and improved exercise endurance in mice.
Additional mouse research found increased energy expenditure and fatty-acid oxidation, along with reductions in fat-mass accumulation and improvements in insulin sensitivity in models of obesity and metabolic syndrome.
The Science Behind SLU-PP-332
SLU-PP-332 activates all three ERR subtypes — ERRα, ERRβ, and ERRγ — with the greatest activity toward ERRα. These receptors function as important regulators of genes involved in mitochondrial metabolism and the physiological response to exercise.
Rather than acting as a traditional stimulant, SLU-PP-332 is being investigated for its ability to influence the cellular metabolic machinery associated with exercise adaptation.
Why Researchers Are Interested
The potential of SLU-PP-332 lies in its ability to target pathways involved in:
Mitochondria → Fat Oxidation → Energy Production → Muscle Adaptation → Endurance
This makes it particularly interesting for research involving metabolic health, exercise physiology, mitochondrial biology, and skeletal-muscle performance.
Important Research Note
The current evidence for SLU-PP-332 is predominantly preclinical, including cell and animal studies. It has not been established as a safe or effective exercise-mimetic therapy in humans, and human dosing cannot be inferred from the animal studies.
Research Use Only
This product is supplied for laboratory and research purposes only. It is not FDA-approved and is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease or medical condition.
Stack Science™
Performance. Recovery. Longevity.
Compound Information
What Is SLU-PP-332?
A small-molecule pan-agonist of the estrogen-related receptors (ERR-alpha, ERR-beta, ERR-gamma), studied as an exercise-mimetic compound for its effects on mitochondrial biogenesis and metabolic gene expression.
Stability Information
This compound is stable as a dry solid at room temperature for short periods but is best kept refrigerated or frozen, sealed, and protected from light and moisture for long-term storage.
